| 1 |
34774850 | Flotillin-1 promotes progression and dampens chemosensitivity to cisplatin in gastric cancer via ERK and AKT signaling pathways. | 2022 Feb 5 |
1 |
| 2 |
35196205 | Circular RNA SET domain protein 3 promotes nasopharyngeal carcinoma proliferation, cisplatin resistance, and protein kinase B / mammalian target of rapamycin pathway activation by modulating microRNA-147a expression. | 2022 Mar |
1 |
| 3 |
35238281 | BEZ235 reduction of cisplatin resistance on wild-type EGFR non-small cell lung cancer cells. | 2022 Mar 3 |
1 |
| 4 |
35256453 | Agmatine Alleviates Cisplatin-Induced Ototoxicity by Activating PI3K/AKT Signaling Pathway. | 2022 Mar-Apr |
1 |
| 5 |
35628594 | Nimodipine Treatment Protects Auditory Hair Cells from Cisplatin-Induced Cell Death Accompanied by Upregulation of LMO4. | 2022 May 21 |
1 |
| 6 |
33813077 | Suppressing CHD1L reduces the proliferation and chemoresistance in osteosarcoma. | 2021 May 21 |
1 |
| 7 |
34277781 | A novel peptide promotes human trophoblast proliferation and migration through PI3K/Akt/mTOR signaling pathway. | 2021 Jun |
1 |
| 8 |
34313839 | Pyk2 level is a novel prognostic marker for patients with esophageal squamous cell carcinoma after radical surgery. | 2021 Nov |
1 |
| 9 |
34411338 | Methylseleninic acid overcomes programmed death-ligand 1-mediated resistance of prostate cancer and lung cancer. | 2021 Nov |
1 |
| 10 |
34522245 | Downregulation of long non-coding RNA B-Raf proto-oncogene-activated non-coding RNA reverses cisplatin resistance in laryngeal squamous cell carcinoma. | 2021 |
1 |
| 11 |
31814556 | Ginsenoside Rh2 Improves the Cisplatin Anti-tumor Effect in Lung Adenocarcinoma A549 Cells via Superoxide and PD-L1. | 2020 |
1 |
| 12 |
32627280 | Deoxyshikonin inhibits cisplatin resistance of non-small-cell lung cancer cells by repressing Akt-mediated ABCB1 expression and function. | 2020 Oct |
1 |
| 13 |
32945500 | Inactivation of AKT/NF‑κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatin. | 2020 Oct |
1 |
| 14 |
33024577 | Arsenic trioxide enhances the chemotherapeutic efficiency of cisplatin in cholangiocarcinoma cells via inhibiting the 14-3-3ε-mediated survival mechanism. | 2020 |
2 |
| 15 |
30417422 | Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression. | 2019 May |
1 |
| 16 |
29518977 | Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach. | 2018 Mar 7 |
3 |
| 17 |
29970878 | Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT. | 2018 Jul 3 |
1 |
| 18 |
27581532 | Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy. | 2016 Nov |
1 |
| 19 |
24960055 | Hexabromocyclododecane and polychlorinated biphenyls increase resistance of hepatocellular carcinoma cells to cisplatin through the phosphatidylinositol 3-kinase/protein kinase B pathway. | 2014 Aug 17 |
1 |
| 20 |
19880522 | Pyk2 inhibition of p53 as an adaptive and intrinsic mechanism facilitating cell proliferation and survival. | 2010 Jan 15 |
1 |
| 21 |
10187797 | Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinase-dependent mechanism. | 1999 Apr 9 |
3 |